EUVIMEDEUVIMED entdecken
Crossref

Neuroprotective and anti-inflammatory effects of the RIPK3 inhibitor GSK872 in an MPTP-induced mouse model of Parkinson's disease

Jin-Sun Park, Yea-Hyun Leem, Do-Yeon Kim, Jae-Min Park, Seong-Eun Kim, Hee-Sun Kim

Neurochemistry International · 2024-12 · 181 · 105896

DOI: 10.1016/j.neuint.2024.105896 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurochemistry International, 2024-12. Verfasst von Jin-Sun Park und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Inflammation-Cancer Microenvironment Research Center, School of Medicine, Ewha Womans University, Seoul, South Kore…. Hauptthemen laut MEDLINE: Neuroprotective Agents, Receptor-Interacting Protein Serine-Threonine Kinases, Mice, Inbred C57BL. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's disease (PD) is a neurodegenerative disorder triggered by the loss of dopaminergic neurons in the substantia nigra (SN). Recent studies have demonstrated that necroptosis is involved in dopaminergic neuronal cell death and the resulting neuroinflammation. During the process of necroptosis, a necrosome complex is formed consisting of the proteins receptor-interacting protein kinase 1 (RIPK1), RIPK3, and mixed lineage kinase domain-like protein (MLKL). Although the neuroprotective effects of the RIPK1-specific inhibitor necrostatin-1, as well as RIPK3 and MLKL knockout in mice, have been described, the effects of RIPK3 pharmacological inhibitors have not yet been reported in animal models of PD. In the present study, we investigated the neuroprotective effects of GSK872, a specific RIPK3 inhibitor, in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of PD. GSK872 rescued MPTP-induced motor impairment and inhibited tyrosine hydroxylase-positive dopaminergic cell death in the SN and striatum. Additionally, GSK872 inhibited the MPTP-induced increase in the expression of p-RIPK3 and p-MLKL in both the dopaminergic neurons and microglia, as assessed by biochemical and histological analyses. GSK872 further inhibited microglial activation and the expression of inflammatory mediators including NLRP3, interleukin (IL)-1β, IL-6, tumor necrosis factor-alpha, and inducible nitric oxide synthase in the SN region of MPTP mice. Using in vitro experiments, we validated the effects of GSK872 on necroptosis in SH-SY5Y neuronal and BV2 microglial cells. Overall, our results suggest that GSK872 exerts neuroprotective and anti-inflammatory effects, and may thus have therapeutic potential for PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroprotective AgentsReceptor-Interacting Protein Serine-Threonine KinasesMice, Inbred C57BLAnimalsMiceMaleAnti-Inflammatory AgentsDopaminergic NeuronsMPTP PoisoningDisease Models, Animal1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Stichwörter der Autor:innen

GSK872NecroptosisNeuroinflammationNeuroprotectionParkinson's diseaseRIPK3

Substanzen

Neuroprotective AgentsReceptor-Interacting Protein Serine-Threonine KinasesRipk3 protein, mouseAnti-Inflammatory Agents1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Autor:innen und Institutionen

  • Department of Molecular Medicine, Inflammation-Cancer Microenvironment Research Center, School of Medicine, Ewha Womans University, Seoul, South Korea.
  • Department of Molecular Medicine, Inflammation-Cancer Microenvironment Research Center, School of Medicine, Ewha Womans University, Seoul, South Korea; Department of Brain & Cognitive Sciences, Ewha Womans University, S…

Zitieren

APA

Park, J. S., Leem, Y. H., Kim, D. Y., Park, J. M., Kim, S. E., & Kim, H. S. (2024). Neuroprotective and anti-inflammatory effects of the RIPK3 inhibitor GSK872 in an MPTP-induced mouse model of Parkinson's disease. Neurochemistry International, 181, 105896. https://doi.org/10.1016/j.neuint.2024.105896

Vancouver

Park JS, Leem YH, Kim DY, Park JM, Kim SE, Kim HS. Neuroprotective and anti-inflammatory effects of the RIPK3 inhibitor GSK872 in an MPTP-induced mouse model of Parkinson's disease. Neurochemistry International. 2024;181:105896. doi:10.1016/j.neuint.2024.105896

BibTeX
@article{Park2024,
  author = {Park, Jin-Sun and Leem, Yea-Hyun and Kim, Do-Yeon and Park, Jae-Min and Kim, Seong-Eun and Kim, Hee-Sun},
  title = {Neuroprotective and anti-inflammatory effects of the RIPK3 inhibitor GSK872 in an MPTP-induced mouse model of Parkinson's disease},
  journal = {Neurochemistry International},
  year = {2024},
  volume = {181},
  pages = {105896},
  doi = {10.1016/j.neuint.2024.105896}
}
Kostenlos starten →